Mitochondria! (mt)DNA is strictly maternally inherited in mammals; new mutations thus segregate along maternal lineages without the benefit of homologous recombination with mtDNA of paternal origin. Despite the high mtDNA copy number (-100 000 or more) in mature oocytes, and despite the relatively small number of cell divisions during oogenesis, mtDNA sequence variants segregate rapidly between generations. This paradoxical behaviour has been ascribed to the presence of a mtDNA 'bottleneck' in oogenesis or early embryogenesis. The nature and size of this bottleneck have been the subject of much controversy. This review argues that segregation of mtDNA sequence variants in the female germline occurs primarily during mitosis in the oocyte precursor population. Segregation is rapid because the precursor cells (primordial germ cells and oogonia) contain a relatively small number of mtDNA templates (the bottleneck) and because the replication of mtDNA is under relaxed control. For the most part, the process appears similar in mice segregating polymorphic sequence variants and in human pedigrees segregating pathogenic point mutations. In particular, there is no evidence for selection against high levels of pathogenic mtDNA point mutations in oogenesis, in early embryonic development, or in fetal development, thus suggesting that efficient respiratory chain function is not critical until post-natal life. These results have important practical implications for clinical genetics.
Introduction
Mammalian mitochondrial DNA (mtDNA) comprises a small double-stranded circular molecule that codes for 13 polypeptides in the enzyme complexes of the mitochondrial respiratory chain, and the tRNAs and rRNAs necessary for their translation. It is strictly maternally inherited in mammals (Giles et al., 1980; Kaneda et al., 1995) ; new sequence variants are transmitted along maternal lineages without recombination with male mtDNA. Most somatic cells have ~10 3 -10 4 copies of mtDNA, organized as 2-10 copies per organelle (Nass, 1969; Satoh and Kuroiwa, 1991) ; oocytes have ~10 5 copies and a similar number of mitochondria (Piko and Taylor, 1987) , which implies that, at least on average, oocyte mitochondria contain just one or so mtDNA copy per organelle. In contrast to nuclear DNA, replication of mtDNA is not linked to the cell cycle (Clayton, 1982 (Clayton, , 2000 . This 'relaxed' form of replication allows some templates to replicate more than once during the cell cycle, with others not replicating at all. Thus, while mtDNA copy number is tightly regulated in a cell-and tissue-specific manner (by unknown mechanisms), sequence variants can segregate during mitosis due to unequal replication from templates in the parent cell and random sampling of mtDNAs at cytokinesis (Birky, 1994) . In the absence of selection, the rate of segregation of mtDNA sequence variants depends primarily on two parameters: mtDNA copy number and the number of mitotic divisions.
Major advances in our understanding of the molecular basis for respiratory chain deficiencies have occurred over the last decade (Larsson and Clayton, 1995; Grossman and Shoubridge, 1996; Lightowlers et al, 1997; Shoubridge, 1998) . It is now clear that mutations in mtDNA are an important cause of disease, especially in the adult population. In most cases the mutant and wild-type mtDNAs are present together in the same individual, a situation referred to as mtDNA heteroplasmy. This has focused renewed attention on the rules governing the transmission of mtDNA mutations between generations. New reproductive technologies, e.g. intracytoplasmic sperm injection (ICSI), have also forced re-evaluation of the potential contribution of male mtDNA to the zygote. Here I will review the evidence for the so-called mtDNA bottleneck, its effect on segregation of mtDNA, and the implications of this phenomenon for prenatal and preimplantation diagnosis and genetic counselling of carriers of mtDNA mutations.
What is the mtDNA bottleneck and where does it occur?
Despite the very large copy number (~10 5 or more) of mtDNA in the female gamete and the limited number of mitotic divisions in the development of the female germline, mtDNA sequence variants often segregate rapidly between generations. Thus, while most individuals contain a single mtDNA genotype (mtDNA homoplasmy), sequence variation between individuals in human populations is typically of the order of 0.3%, or -50 nucleotides. New mutations that arise in the female germline produce a transient heteroplasmic state, which usually resolves itself within relatively few generations. These observations were first made by Hauswirth and Laipis in maternal lineages of Holstein cows, where it was observed that a sequence variant in the mtDNA D-loop (the triple stranded, noncoding, hypervariable region of the molecule) could segregate completely in a few generations Olivo et al, 1983; Ashley et al, 1989) . This led these investigators to propose the existence of an intergenerational bottleneck for the transmission of mtDNA. They suggested that it could result from use of a limited number of mtDNA templates during what they assumed was a 100-fold amplification of mtDNA copy number accompanying the maturation of the primary to the pre-ovulatory oocyte (see below), reducing the effective number of mtDNAs that contribute to the next generation. Similar studies by Koehler et al. (1991) on more than 30 independent maternal lineages showed complete allele switching (of the same D-loop sequence variant) within a single generation in 40% of the mother-daughter pairs they examined, suggesting that the size of the bottleneck could be as small as a single mtDNA molecule. Rapid segregation of pathogenic mtDNA mutations has also been observed in a large number of human pedi-grees, suggesting that the phenomenon is likely to be universal in mammals (Jenuth et al, 1996) .
Much of the controversy surrounding the nature of the mtDNA bottleneck revolves around the definition of the term 'bottleneck'. Some have interpreted it to be a process, while others suggest it is a physical restriction in the number of mitochondrial genomes. In the language of population genetics, a bottleneck refers to a period when the number of breeding individuals in a population (and hence the amount of genetic variation) is reduced to a very small number relative to earlier or later (e.g. current) numbers. A population that passes through such a bottleneck, having expanded from a limited number of founder genotypes, will have a much reduced genetic variation, sometimes with exaggerated frequencies of rare alleles. To identify the bottleneck for transmission of mtDNA, we must therefore identify a stage in the development of the female germline either where the number of copies of mtDNA is reduced to a small number relative to the number in a mature oocyte or where a small number of molecules are chosen as founders for all of the mtDNAs that are transmitted to the next generation.
Ultrastructural analyses in the human indicate that primordial germ cells (PGCs) have -10 mitochondria, increasing to -200 in oogonia and to several thousand in the oocyte in a primordial follicle (Jansen and De Boer, 1998) . Measurements of mtDNA copy number in immature oocytes of the mouse (<20 |im in diameter) suggest that there are ~10 3 copies (Piko and Taylor, 1987) . As the oocyte matures to >80 (im in diameter, the number of mtDNAs increases -100-fold to -100 000, organized as approximately one per organelle (Piko and Taylor, 1987) . In the cow, this number is -200 000 and the oocytes are larger (Michaels et al, 1982) . The mtDNA copy number is not known in either PGCs or in oogonia. It has been suggested that oogenesis is accompanied by a reduction in mtDNA copy number per organelle (Laipis et al, 1988) , implying that there are multiple mtDNA copies per organelle in the oocyte precursors, but there is no direct evidence for this proposition. Others have proposed that mtDNA copy number might be one per organelle throughout all stages of oogenesis (Jansen and De Boer, 1998) . Even if it is assumed that the copy number per organelle in the germ cell precursor population is similar to that in somatic cells (approximately five per organelle), it is clear that there is at least a 2000-fold increase in mtDNA copy number during oogenesis, from perhaps as many as 50 in the PGCs to 10 5 in the pre-ovulatory oocyte.
After fertilization, cell division of the early embryo proceeds without mtDNA replication (Piko and Taylor, 1987) , so that by the time the inner cell mass cells are set aside in the blastocyst (-100 cells), mtDNA copy number per cell is reduced to -10 3 , in the same range as in most somatic cells. Replication of mtDNA restarts sometime after implantation; how this is regulated is unknown.
The morphological evidence clearly indicates a physical bottleneck in the number of mitochondria (hence mtDNAs) in the PGC population; however, the mechanisms that mediate this 100-fold reduction in organelle number from the cells in the inner cell mass are unknown. It could be simply a continuation of the dilution of mtDNA and mitochondria that occurs in the preimplantation embryo. Whether this reduction in mtDNA copy number is sufficient to account for the observed rate of segregation of sequence variants, or whether there is a further restriction in the number of founder mtDNAs at a later stage of oogenesis ), has recently been tested (Jenuth et al, 1996) .
Testing the bottleneck hypothesis
The mechanism responsible for the rapid segregation of mtDNA has been investigated in heteroplasmic mice constructed from two different Mas mus domesticus strains, NZB and BALB/c (Jenuth et ah, 1996) . Single cell mtDNA PCR of mature oocytes, primary oocytes and PGCs was used to examine the evolution of genetic variance during oogenesis. The study demonstrated that nearly all of the segregation of sequence variants had occurred by the time the primary oocyte population had formed, but that there was little intercellular variation in the degree of mtDNA heteroplasmy in the PGC population. These data squarely place most of the segregation of mtDNA sequence variants in the mitotic divisions that occur in the migratory PGC and oogonial populations. They further demonstrate that segregation between the primary oocyte in the resting primordial follicle and the mature oocyte at ovulation is quantitatively unimportant. These results strongly suggest that there is a single location for the bottleneck for the transmission of mtDNA, the oocyte precursor population. Studies of homopolymeric tract heteroplasmy in humans are consistent with the mouse studies, showing that segregation has occurred by the time oocytes are mature (Marchington et al., 1997) .
This model (mtDNA segregation by random genetic drift) appears to provide an adequate explanation for the rapid amplification and fixation of new mtDNA mutations in the female germline. New mutations, which would be rare in the population of PGCs and oogonia, could increase in frequency in individual oocytes during, especially during meiosis I in fetal life, due to the relatively small number of founder mitochondria in these precursor cells. Mutations arising later in oogenesis, when mtDNA copy number is already high, ought to be relatively unimportant.
Using a population genetic model, the effective number of segregating units of mtDNA has been estimated at -200 in the mouse (Jenuth et ah, 1996) . This is in broad agreement with estimates obtained from segregating pathogenic point mutations in human pedigrees, thus suggesting that the process could be similar. If anything, segregation would be predicted to be faster in humans (assuming the number of PGCs to be similar) because a larger number of oocytes are generated than in the mouse (Jenuth et al., 1996) . One notable exception concerns a point mutation at position 8993 in the gene coding for the ATP6 subunit of ATPsynthase, which is associated with the neuropathy-ataxia-retinitis pigmentosa (NARP) syndrome. For an unknown reason, this mutation appears to segregate much more rapidly than other known pathogenic mutations and the segregation favours the mutant allele (Santorelli et ah, 1994; Tulinius et ah, 1995; Degoul et ah, 1997; Seller et ah, 1997; Uziel et ah, 1997) . This is in sharp contrast to other point mutations where it appears that segregation to either the mutant or wild-type allele appears equally likely (discounting ascertainment bias).
One point does seem clear from the analysis of human pedigrees: there is no evidence for selection against oocytes that carry high levels of point mutations which are pathogenic in later life. This implies that fully efficient respiratory chain function is not critical during oogenesis or early embryogenesis, casting doubt on attempts to relate defects in respiratory chain function to problems of female fertility.
Lack of segregation of mtDNA sequence variants during fetal life
There is abundant opportunity for mitotic segregation of mtDNA sequence variants during the development of the fetus once mtDNA replication resumes after the early embryonic period. The evidence, however, indicates that segregation of mtDNA sequence variants is quite minor until at least after birth. Studies of polymorphic sequence variants in hetero-plasmic mice demonstrated that the relative proportions of two polymorphic sequence variants were very similar among different tissues of newborn heteroplasmic mice (Jenuth et al., 1997) . There are also several reports of the distribution of pathogenic mutations in human fetal tissues (Harding et al., 1992; Matthews et al., 1994) , showing that the frequency of the mutant allele is remarkably uniform among tissues. Two important conclusions can be drawn from these results: (i) mitotic segregation of mtDNA is quantitatively unimportant during fetal life; and (ii) there is no strong selection either for or against sequence variants that affect respiratory chain function during fetal life.
Genetic counselling, prenatal and preimplantation diagnosis
The issues discussed here have important practical implications for clinical genetics. Genetic counselling of women who are carrying mtDNA mutations has been highly problematical (Dahl, 2000) . If, as the data suggest, segregation of mtDNA sequence variants can be treated as a problem of binomial sampling, and if the effective number of segregating units were known, it should be possible to assign a probability to germline entry and dosage, and hence to the risk of recurrence in a future sibling (Marchington et al., 1998) . Whether this will ever be truly useful remains to be seen; the confidence limits on the estimates of risk might be too large to be of value. Even a casual examination of human pedigrees that permit observation of segregating mtDNA point mutations reveals that while the risk of having an affected child increases with the level of heteroplasmy in the mother there is no degree of heteroplasmy at which the risk is low enough to be ignored. The prospects for preimplantation or prenatal diagnosis are considerably brighter. Since an individual's mtDNA genotype is probably determined by the relative proportions of wildtype and mutant mtDNA in the oocyte, the mtDNA genotype of a blastomere sampled from an 8-cell embryo (which should contain >10 000 copies of mtDNA), ought to be a random sample of the oocyte's mtDNA complement and hence a good predictor of the mtDNA genotype of the fetus. The fact that little if any segregation of mtDNA sequence variants occurs during fetal life, even with those that have been proven to be pathogenic (see above), suggests that sampling of any fetal tissue (chorionic villus, amniocytes) after establishment of pregnancy ought also to provide a reliable indication of the overall mtDNA mutation load. However, a word of caution needs to be inserted here: while logical, these assertions are based on very little data. Although it is comforting that polymorphic sequence variants in mice seem to behave in a similar fashion to pathogenic sequence variants in humans, it is not known if all pathogenic mtDNA mutations will obey the same rules. Until such time as we can develop animal models of these diseases for more systematic study, uncertainty about the extent and importance of mosaicism in the oocyte population and the segregation behaviour of different pathogenic mutations will remain.
